Tecan unveils Spark® Cyto plate reader with real-time image cytometry
Tecan is launching the innovative Spark® Cyto plate reader at SLAS Europe 2019 in Barcelona, Spain, from the 26th to the 28th of June. The unique system is the first live cell plate reader to offer real-time detection and analysis of biological, chemical and physical events – capturing the maximum amount of data from every well, at the same time and under the same conditions. Building on the success of the original Spark platform, it combines the flexibility of a high-end multimode plate reader with whole well imaging and comprehensive environmental control for cell-based assays.
Spark Cyto uses top-of-the-range camera components and a patent-pending LED autofocus system to provide real-time data acquisition and analysis – for 6- to 384-well formats – ensuring that no key event is ever missed. It allows qualitative and quantitative information to be integrated into unique multiparametric data sets, delivering meaningful insights faster than ever before. With three magnification levels and four acquisition channels, it enables entire cell populations to be investigated by capturing the whole well area of 96- or 384-well microplates in just one image, without tiling or distortion.
Photo: The Spark Cyto is the first live cell plate reader to offer real-time detection and analysis of biological, chemical and physical events.
Powerful SparkControl™ and Image Analyzer™ software give the operator complete control of all experimental parameters, with predefined methods for common cytometry applications. Together with user-programmable advanced features – such as Real Time Experimental Control (REC™) for automatic performance of kinetic experiments – this unlocks new possibilities for cell-based research.
Dr Fabio Gasparri, Head of Cell Assays at Nerviano Medical Sciences and an early user of Spark Cyto, commented: “I was impressed by the system’s automated cell incubation and analysis capabilities. Cells were growing with a similar doubling times, and even more homogeneously, compared to a dedicated cell incubator approach. The whole well imaging capability for 96-well plates allowed reproducible analysis in real time.”
Dr Valery Bochkov, Professor of Molecular Pharmaceutics at the University of Graz, Austria, agreed: “Using the Spark Cyto for cell imaging, enzymatic tests and immunoassays, we were impressed by how intuitive and easy to use the software is. Our diploma and PhD students instantly learned how to work with Spark Cyto and obtain high quality results.”
Visit Tecan on Island 3 at SLAS Europe 2019 to discover the Spark Cyto for yourself, or go to www.tecan.com/sparkcyto
Keywords: Real-time cytometry; live cell imaging; whole well imaging; cell-based assays; kinetic experiments
About Us
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2018, Tecan generated sales of CHF 594 million (USD 606 million; EUR 516 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
Über Tecan
Tecan (www.tecan.com) ist ein weltweit führender Anbieter von Laborinstrumenten und Lösungen für die Branchen Biopharma, Forensik und Klinische Diagnostik. Das Unternehmen ist auf Entwicklung, Herstellung und Vertrieb von Automatisierungslösungen für Laboratorien im Life-Science-Bereich spezialisiert. Die Kunden von Tecan sind Pharma- und Biotechnologieunternehmen, Forschungs-abteilungen von Universitäten sowie forensische und diagnostische Laboratorien. Als Originalgeräte-hersteller (OEM) ist Tecan auch führend in der Entwicklung und Herstellung von OEM-Instrumenten und Komponenten, die vom jeweiligen Partnerunternehmen vertrieben werden. Tecan wurde 1980 in der Schweiz gegründet. Das Unternehmen verfügt über Produktions-, Forschungs- und Entwicklungs-stätten in Europa und in Nordamerika. In 52 Ländern unterhält es ein Vertriebs- und Servicenetz. Im Jahr 2016 erzielte Tecan einen Umsatz von CHF 594 Mio. (USD 606 Mio.; EUR 516 Mio.). Die Namenaktien der Tecan Group werden an der SIX Swiss Exchange gehandelt (TECN; ISIN CH0012100191).
Contacts
Sarah Ballard
ideas@kdm-communications.comkdm communications limited, St Neots, UK
Phone: +44 (0) 1480 405333 Mobile: +44 (0) 1480 477833
Links